Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiro Hide

Showing results (261-270 of 287) with videos related to

Pageof 29
Sort By:
Allergology International : Official Journal of the Japanese Society of Allergology|December 5, 2022
Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in JapanRiko Takimoto-Ito, Naotomo Kambe, Toshiaki Kogame, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 6, 2025
Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World StudyReineke Soegiharto, Esther Van der Wind, Mehran Alizadeh Aghdam, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Arerugi = [Allergy]|April 12, 2026
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Medicine|September 22, 2020
Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocolTakeshi Nakahara, Kenji Izuhara, Daisuke Onozuka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 5, 2026
Family quality-of-life burden in chronic spontaneous urticaria: A multicentre studyBeatrice Martinez Zugaib Abdalla, Roberta Fachini Jardim Criado, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology. Global|September 10, 2024
Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitisMakiko Kido-Nakahara, Daisuke Onozuka, Kenji Izuhara, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 16, 2022
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)Takeshi Nakahara, Kenji Izuhara, Daisuke Onozuka, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2019
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergyEmiko Noguchi, Masato Akiyama, Akiko Yagami, et al.
Pageof 29

Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
Allergology International : Official Journal of the Japanese Society of Allergology|December 5, 2022
Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in JapanRiko Takimoto-Ito, Naotomo Kambe, Toshiaki Kogame, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 6, 2025
Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World StudyReineke Soegiharto, Esther Van der Wind, Mehran Alizadeh Aghdam, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and TreatmentBruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Arerugi = [Allergy]|April 12, 2026
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Medicine|September 22, 2020
Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocolTakeshi Nakahara, Kenji Izuhara, Daisuke Onozuka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 5, 2026
Family quality-of-life burden in chronic spontaneous urticaria: A multicentre studyBeatrice Martinez Zugaib Abdalla, Roberta Fachini Jardim Criado, Kanokvalai Kulthanan, et al.
The Journal of Allergy and Clinical Immunology. Global|September 10, 2024
Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitisMakiko Kido-Nakahara, Daisuke Onozuka, Kenji Izuhara, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 16, 2022
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)Takeshi Nakahara, Kenji Izuhara, Daisuke Onozuka, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2019
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergyEmiko Noguchi, Masato Akiyama, Akiko Yagami, et al.
Pageof 29